
Lab Automation For In Vitro Diagnostic
Lab Automation For In-Vitro Diagnostic Market Forecasts to 2030 - Global Analysis By Product (Reagents and Kits, Instruments, Data Management Software and Other Products), Equipment (Automated Plate Handler, Automated Liquid Handler, Robotic Arm, Automated Storage and Retrieval System, Analyzer and Other Equipments), Technology, Application, End User and By Geography

According to Stratistics MRC, the Global Lab Automation for In-Vitro Diagnostic Market is accounted for $131.59 billion in 2024 and is expected to reach $193.09 billion by 2030 growing at a CAGR of 6.60% during the forecast period. Medical laboratory operations are completely transformed by lab automation for in-vitro diagnostics, which increases productivity by optimizing workflows. Tasks like sample preparation, analysis, and data management are automated, lowering human error and boosting throughput by combining sophisticated robotics, software, and instrumentation. With the help of this technology, patients can receive a diagnosis and make treatment decisions more quickly thanks to rapid and accurate testing.
According to the American Association for Clinical Chemistry (AACC), laboratory automation plays a crucial role in modern healthcare by improving efficiency, reducing errors, and ultimately enhancing patient care outcomes.
Market Dynamics:
Driver:
Growing requirement for high-throughput evaluation
Clinical diagnostics, genomics, drug discovery, and other fields are finding increasing applications for high-throughput screening (HTS) techniques. With HTS, a large compound library can be quickly screened to find possible drug candidates in the drug discovery process. Moreover, the analysis of massive genomic data for uses like cancer genomics and personalized medicine is similarly made easier in the field of genomics by HTS technologies like next-generation sequencing (NGS).
Restraint:
Excessive initial capital outlay
Lab automation system implementation necessitates a large upfront investment in personnel training, software, hardware, and infrastructure. For laboratories, especially smaller ones with tighter budgets, the high cost of automation platforms such as robotic systems, liquid handling workstations, and integrated laboratory information management systems (LIMS) can be a financial burden. Furthermore, the total cost of ownership is further increased by continuing costs for software updates, calibration, and maintenance, which may discourage adoption among budget-conscious businesses.
Opportunity:
Point-of-care testing (POCT) expansion
Point-of-care testing (POCT) is becoming more widely used in a variety of healthcare settings, such as clinics, pharmacies, hospitals, and community-based facilities. This is due to the growing demand for decentralized testing solutions and quick diagnostic services. Moreover, by enabling on-site testing, real-time result delivery, and prompt clinical intervention, POCT devices, handheld analyzers, portable diagnostic instruments, and smart phone-based applications improve patient access to timely diagnosis and healthcare outcomes.
Threat:
Market Saturation and vigorous rivalry
A wide range of automation solutions and diagnostic assays are offered by a number of global players, specialized manufacturers, and start-ups in the fiercely competitive lab automation for in-vitro diagnostics market. Market saturation puts downward pressure on profit margins and revenue growth for industry incumbents, especially when combined with fierce price competition and the commoditization of automation platforms. Additionally, the rise of substitute products, disruptive technologies, and new competitors increases the pressure on existing ones, causing price wars, market share erosion, and market consolidation.
Covid-19 Impact:
The market for lab automation for in-vitro diagnostics has been significantly impacted by the COVID-19 pandemic, which has brought about both opportunities and challenges. Although the pandemic slowed market growth initially due to supply chain disruptions, manufacturing delays, and healthcare facilities temporarily closing, it also accelerated the adoption of automation technologies to meet the spike in demand for diagnostic testing. Furthermore, solutions for laboratory automation were essential in helping to support pandemic response efforts and enable the safe reopening of economies by increasing testing capacity, optimizing sample processing, and shortening turnaround times for COVID-19 testing.
The Reagents and Kits segment is expected to be the largest during the forecast period
Reagents and kits usually have the largest market share in the lab automation for in-vitro diagnostics market. These necessary elements include a broad range of materials, such as biochemical, antibodies, and probes that are utilized in diagnostic testing procedures. From simple blood analyses to intricate molecular diagnostics, reagents and kits are the cornerstone of many tests. Moreover, their ubiquity is attributed to their necessity in a variety of diagnostic applications as well as the ongoing need for precise and effective testing methods.
The Automated Liquid Handler segment is expected to have the highest CAGR during the forecast period
In the lab automation for in vitro diagnostic market, the automated liquid handler usually exhibits the highest CAGR. With the least amount of human involvement, automated liquid handlers simplify the process of precisely dispensing liquids—such as reagents and samples—into different containers, plates, or tubes. With the help of this technology, laboratory workflows can be made much more efficient, accurate, and productive. Additionally, the growing need for quicker and more standardized diagnostic processes, as well as the need to lower errors and enhance reproducibility in laboratory operations, are what are driving the increasing adoption of automated liquid handling systems.
Region with largest share:
The market for lab automation for in-vitro diagnostics is dominated by North America. The region's early adoption of cutting-edge technologies, substantial investment in research and development, and sophisticated healthcare infrastructure are all credited with its dominance. Leading market participants, supportive government policies, and financing for medical research all contribute to North America's dominant position in the industry. Furthermore, the need for effective and precise diagnostic solutions is fueled by the aging population and the high prevalence of chronic diseases.
Region with highest CAGR:
The lab automation for in-vitro diagnostic market is anticipated to grow at the highest CAGR in the Asia-Pacific region. Numerous factors, such as rising healthcare costs, growing healthcare infrastructure, and a growing emphasis on advanced diagnostic technologies, are responsible for this rapid growth. The need for effective and precise diagnostic tools is fueled by the aging population and the rising incidence of chronic diseases. Additionally, the area also gains from significant public and private healthcare investments, as well as from supportive government programs targeted at modernizing laboratory services.
Key players in the market
Some of the key players in Lab Automation For In-Vitro Diagnostic market include F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Cognex Corporation, Quidel Corporation, Abbott Laboratories, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Chembio Diagnostics, Inc, Bio-Rad Laboratories, Inc., Surmodics, Inc., Danaher Corporation, Tecan Group Ltd, Sysmex Corporation, Agilent Technologies Inc. and PerkinElmer Inc.
Key Developments:
In January 2024, BD (Becton, Dickinson and Company), a leading global medical technology company, announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multiomics experiments.
In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc. (“Carmot”), a privately owned US company based in Berkeley, California. Carmot’s R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.
In August 2023, Cognex Corporation, a leader in industrial machine vision, announced it has agreed to acquire Moritex Corporation (Moritex) from Trustar Capital, a private equity affiliate of CITIC Capital Holdings Limited, for ¥40 billion (approximately $275 million), in an all-cash transaction. Moritex is a leading global provider of optics components with a strong presence in Japan.
Products Covered:
• Reagents and Kits
• Instruments
• Data Management Software
• Other Products
Equipments Covered:
• Automated Plate Handler
• Automated Liquid Handler
• Robotic Arm
• Automated Storage and Retrieval System
• Analyzer
• Other Equipments
Technologies Covered:
• Immunoassay/ Immunochemistry
• Clinical Chemistry
• Hematology
• Molecular Diagnostics
• Microbiology
• Coagulation And Hemostasis
• Urinalysis
• Other Technologies
Applications Covered:
• Infectious Diseases
• Diabetes
• Drug Testing/ Pharmacogenomics
• Autoimmune Diseases
• Oncology
• Cardiology
• HIV/AIDS
• Nephrology
• Other Applications
End Users Covered:
• Hospital Laboratories
• Point-Of-Care Testing Centers
• Academic Institutes
• Clinical Laboratories
• Patients
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Lab Automation For In-Vitro Diagnostic Market, By Product
5.1 Introduction
5.2 Reagents and Kits
5.3 Instruments
5.4 Data Management Software
5.5 Other Products
6 Global Lab Automation For In-Vitro Diagnostic Market, By Equipment
6.1 Introduction
6.2 Automated Plate Handler
6.3 Automated Liquid Handler
6.4 Robotic Arm
6.5 Automated Storage and Retrieval System
6.6 Analyzer
6.7 Other Equipments
7 Global Lab Automation For In-Vitro Diagnostic Market, By Technology
7.1 Introduction
7.2 Immunoassay/ Immunochemistry
7.3 Clinical Chemistry
7.4 Hematology
7.5 Molecular Diagnostics
7.6 Microbiology
7.7 Coagulation And Hemostasis
7.8 Urinalysis
7.9 Other Technologies
8 Global Lab Automation For In-Vitro Diagnostic Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.3 Diabetes
8.4 Drug Testing/ Pharmacogenomics
8.5 Autoimmune Diseases
8.6 Oncology
8.7 Cardiology
8.8 HIV/AIDS
8.9 Nephrology
8.10 Other Applications
9 Global Lab Automation For In-Vitro Diagnostic Market, By End User
9.1 Introduction
9.2 Hospital Laboratories
9.3 Point-Of-Care Testing Centers
9.4 Academic Institutes
9.5 Clinical Laboratories
9.6 Patients
9.7 Other End Users
10 Global Lab Automation For In-Vitro Diagnostic Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 F. Hoffmann-La Roche Ltd
12.2 Becton, Dickinson and Company
12.3 Cognex Corporation
12.4 Quidel Corporation
12.5 Abbott Laboratories
12.6 Siemens Healthineers AG
12.7 Thermo Fisher Scientific Inc.
12.8 Chembio Diagnostics, Inc
12.9 Bio-Rad Laboratories, Inc.
12.10 Surmodics, Inc.
12.11 Danaher Corporation
12.12 Tecan Group Ltd
12.13 Sysmex Corporation
12.14 Agilent Technologies Inc.
12.15 PerkinElmer Inc.
List of Tables
1 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Region (2022-2030) ($MN)
2 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Product (2022-2030) ($MN)
3 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Reagents and Kits (2022-2030) ($MN)
4 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Instruments (2022-2030) ($MN)
5 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Data Management Software (2022-2030) ($MN)
6 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Products (2022-2030) ($MN)
7 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Equipment (2022-2030) ($MN)
8 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Plate Handler (2022-2030) ($MN)
9 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Liquid Handler (2022-2030) ($MN)
10 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Robotic Arm (2022-2030) ($MN)
11 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Automated Storage and Retrieval System (2022-2030) ($MN)
12 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Analyzer (2022-2030) ($MN)
13 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Equipments (2022-2030) ($MN)
14 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Technology (2022-2030) ($MN)
15 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Immunoassay/ Immunochemistry (2022-2030) ($MN)
16 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Clinical Chemistry (2022-2030) ($MN)
17 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Hematology (2022-2030) ($MN)
18 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
19 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Microbiology (2022-2030) ($MN)
20 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Coagulation And Hemostasis (2022-2030) ($MN)
21 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Urinalysis (2022-2030) ($MN)
22 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Technologies (2022-2030) ($MN)
23 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Application (2022-2030) ($MN)
24 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Infectious Diseases (2022-2030) ($MN)
25 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Diabetes (2022-2030) ($MN)
26 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Drug Testing/ Pharmacogenomics (2022-2030) ($MN)
27 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Autoimmune Diseases (2022-2030) ($MN)
28 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Oncology (2022-2030) ($MN)
29 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Cardiology (2022-2030) ($MN)
30 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By HIV/AIDS (2022-2030) ($MN)
31 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Nephrology (2022-2030) ($MN)
32 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other Applications (2022-2030) ($MN)
33 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By End User (2022-2030) ($MN)
34 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Hospital Laboratories (2022-2030) ($MN)
35 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Point-Of-Care Testing Centers (2022-2030) ($MN)
36 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Academic Institutes (2022-2030) ($MN)
37 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Clinical Laboratories (2022-2030) ($MN)
38 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Patients (2022-2030) ($MN)
39 Global Lab Automation For In-Vitro Diagnostic Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?

Assured Quality
Best in class reports with high standard of research integrity

24X7 Research Support
Continuous support to ensure the best customer experience.

Free Customization
Adding more values to your product of interest.

Safe & Secure Access
Providing a secured environment for all online transactions.

Trusted by 600+ Brands
Serving the most reputed brands across the world.